SCHEMBL7071774

SCHEMBL7071774

C=CCOc1ccc(C=O)cc1C(c1ccc(OCCC)cc1)c1cc(C=O)ccc1OCC=C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
MAPT P10636 4/20 0.39
HPGD P15428 3/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ERN1 O75460 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38
TUBB6 Q9BUF5 1/20 0.38
TUBB2B Q9BVA1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683656 0.82 ALDH1A1 (0.43) ALDH1A1HPGDLMNAFDPSMEN1
SCHEMBL7072437 0.80 ALDH1A1 (0.49) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL20198556 0.74 MEN1 (0.39) ALDH1A1MAPTLMNASMN1; SMN2MEN1
SCHEMBL20198498 0.74 MEN1 (0.39) ALDH1A1MAPTLMNASMN1; SMN2MEN1
SCHEMBL3133543 0.72 ALDH1A1 (0.62) ALDH1A1MAPTHPGDLMNAFDPS
SCHEMBL7680291 0.71 MAOA (0.53) ALDH1A1SMN1; SMN2TDP1
SCHEMBL7071776 0.71 ERN1 (0.42) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL7068044 0.71 ALDH1A1 (0.53) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL541949 0.71 ALDH1A1 (0.68) ALDH1A1MAPTHPGDLMNASMN1; SMN2
1-Allyloxy-4-Propoxybenzene SCHEMBL2843517 0.71 CA12 (0.50) ALDH1A1MAPTHPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases NITZ THEODORE J (US) 2003-05-15 US disclosed
US-6495580-B1 A BENZYLIDENE DERIVATIVE CONTAINING HETEROCYCLIC RING IS USEFUL AS PNEUMOVIRUS INHIBITOR VIROPHARMA INCORPORATED 2002-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases TTPA, HAVCR2, PML ALDH1A1 3369/4885MAPT 2354/4885HPGD 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.